265 related articles for article (PubMed ID: 29378316)
1. Fragment screening for drug leads by weak affinity chromatography (WAC-MS).
Ohlson S; Duong-Thi MD
Methods; 2018 Aug; 146():26-38. PubMed ID: 29378316
[TBL] [Abstract][Full Text] [Related]
2. Weak affinity chromatography as a new approach for fragment screening in drug discovery.
Duong-Thi MD; Meiby E; Bergström M; Fex T; Isaksson R; Ohlson S
Anal Biochem; 2011 Jul; 414(1):138-46. PubMed ID: 21352794
[TBL] [Abstract][Full Text] [Related]
3. Fragment screening by weak affinity chromatography: comparison with established techniques for screening against HSP90.
Meiby E; Simmonite H; le Strat L; Davis B; Matassova N; Moore JD; Mrosek M; Murray J; Hubbard RE; Ohlson S
Anal Chem; 2013 Jul; 85(14):6756-66. PubMed ID: 23806099
[TBL] [Abstract][Full Text] [Related]
4. Advances with weak affinity chromatography for fragment screening.
Tsopelas F; Tsantili-Kakoulidou A
Expert Opin Drug Discov; 2019 Nov; 14(11):1125-1135. PubMed ID: 31380703
[No Abstract] [Full Text] [Related]
5. Fragment screening of cyclin G-associated kinase by weak affinity chromatography.
Meiby E; Knapp S; Elkins JM; Ohlson S
Anal Bioanal Chem; 2012 Nov; 404(8):2417-25. PubMed ID: 22918538
[TBL] [Abstract][Full Text] [Related]
6. Weak affinity chromatography for evaluation of stereoisomers in early drug discovery.
Duong-Thi MD; Bergström M; Fex T; Svensson S; Ohlson S; Isaksson R
J Biomol Screen; 2013 Jul; 18(6):748-55. PubMed ID: 23479356
[TBL] [Abstract][Full Text] [Related]
7. Comparison of weak affinity chromatography and surface plasmon resonance in determining affinity of small molecules.
Duong-Thi MD; Bergström G; Mandenius CF; Bergström M; Fex T; Ohlson S
Anal Biochem; 2014 Sep; 461():57-9. PubMed ID: 24915639
[TBL] [Abstract][Full Text] [Related]
8. High-throughput fragment screening by affinity LC-MS.
Duong-Thi MD; Bergström M; Fex T; Isaksson R; Ohlson S
J Biomol Screen; 2013 Feb; 18(2):160-71. PubMed ID: 22983162
[TBL] [Abstract][Full Text] [Related]
9. Fragments: where are we now?
Osborne J; Panova S; Rapti M; Urushima T; Jhoti H
Biochem Soc Trans; 2020 Feb; 48(1):271-280. PubMed ID: 31985743
[TBL] [Abstract][Full Text] [Related]
10. SPR-based fragment screening: advantages and applications.
Neumann T; Junker HD; Schmidt K; Sekul R
Curr Top Med Chem; 2007; 7(16):1630-42. PubMed ID: 17979772
[TBL] [Abstract][Full Text] [Related]
11. Fragment-based drug discovery using rational design.
Jhoti H
Ernst Schering Found Symp Proc; 2007; (3):169-85. PubMed ID: 18510103
[TBL] [Abstract][Full Text] [Related]
12. Direct analysis - no sample preparation - of bioavailable cortisol in human plasma by weak affinity chromatography (WAC).
Ohlson S; Kaur J; Raida M; Niss U; Bengala T; Drum CL; Boehm B; Torres AR
J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():438-444. PubMed ID: 28820982
[TBL] [Abstract][Full Text] [Related]
13. Lipodisks integrated with weak affinity chromatography enable fragment screening of integral membrane proteins.
Duong-Thi MD; Bergström M; Edwards K; Eriksson J; Ohlson S; Ying JT; Torres J; Hernández VA
Analyst; 2016 Feb; 141(3):981-8. PubMed ID: 26673836
[TBL] [Abstract][Full Text] [Related]
14. From experimental design to validated hits a comprehensive walk-through of fragment lead identification using surface plasmon resonance.
Giannetti AM
Methods Enzymol; 2011; 493():169-218. PubMed ID: 21371592
[TBL] [Abstract][Full Text] [Related]
15. Fragment based drug design: from experimental to computational approaches.
Kumar A; Voet A; Zhang KY
Curr Med Chem; 2012; 19(30):5128-47. PubMed ID: 22934764
[TBL] [Abstract][Full Text] [Related]
16. High impact technologies for natural products screening.
Koehn FE
Prog Drug Res; 2008; 65():175, 177-210. PubMed ID: 18084916
[TBL] [Abstract][Full Text] [Related]
17. The benefits of constructing leads from fragment hits.
Foloppe N
Future Med Chem; 2011 Jul; 3(9):1111-5. PubMed ID: 21806375
[TBL] [Abstract][Full Text] [Related]
18. Fragment screening: an introduction.
Leach AR; Hann MM; Burrows JN; Griffen EJ
Mol Biosyst; 2006 Sep; 2(9):430-46. PubMed ID: 17153140
[TBL] [Abstract][Full Text] [Related]
19. Establish an automated flow injection ESI-MS method for the screening of fragment based libraries: Application to Hsp90.
Riccardi Sirtori F; Caronni D; Colombo M; Dalvit C; Paolucci M; Regazzoni L; Visco C; Fogliatto G
Eur J Pharm Sci; 2015 Aug; 76():83-94. PubMed ID: 25952103
[TBL] [Abstract][Full Text] [Related]
20. Native State Mass Spectrometry, Surface Plasmon Resonance, and X-ray Crystallography Correlate Strongly as a Fragment Screening Combination.
Woods LA; Dolezal O; Ren B; Ryan JH; Peat TS; Poulsen SA
J Med Chem; 2016 Mar; 59(5):2192-204. PubMed ID: 26882437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
